- 4.4Impact Factor
- 8.8CiteScore
- 21 daysTime to First Decision
Special Issues
Cancers publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
The Clinical, Technological, and Scientific Progress of Boron Neutron Capture Therapy
Deadline: 15 September 2026
New Models of Cancer Care to Improve Patient Experiences and Clinical Outcomes
Deadline: 15 September 2026
Exercise and Cancer Treatment: The Clinical Application of Exercise Oncology
Deadline: 10 September 2026
Cancer Therapy-Related Adverse Events (2nd Edition)
Deadline: 1 September 2026
The Role of Minimally Invasive and Minimally Radical Surgery in Cervical and Endometrial Cancer
Deadline: 1 September 2026
Prostatectomy Today: Surgical Advances in Prostate Cancer Management
Deadline: 1 September 2026
Gastrointestinal Malignancy: Epidemiology and Risk Factors
Deadline: 31 August 2026
Emergencies in Gastrointestinal Surgical Oncology
Deadline: 31 August 2026
Advancing Horizons in Colorectal Surgery: Innovative Approaches and Outcomes
Deadline: 31 August 2026
CAR T-Cell Therapy and Multiple Myeloma
Deadline: 31 August 2026
Feature Review Paper Special Issue in Section Molecular Cancer Biology
Deadline: 31 August 2026
Advancements in “Cancer Biomarkers” for 2025–2026
Deadline: 31 August 2026
of 261

